Reaction

Gastric Dilatation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,645 reports · 31 co-occurring drugs

As of the last recalculation, Gastric Dilatation appears in 1,645 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 16.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Eplerenone1616.016.0
Nicotine Polacrilex Mini1512.812.8
Nicotine Polarilex1512.812.8
Posaconazole Delayed-Release1011.611.6
Teduglutide1211.311.4
Cyclobenzaprine Hydrochloride811.311.3
Linaclotide2210.610.6
Octreotide Acetate2510.510.5
Liothyronine Sodium710.210.2
Granisetron Hydrochloride89.79.7
Granisetron89.79.7
Canakinumab89.49.4
Oxycodone And Acetaminophen168.88.8
Posaconazole118.68.6
Anti-Thymocyte Globulin (Rabbit)57.97.9
Ethyl Alcohol157.07.0
Riociguat155.95.9
Isopropyl Alcohol155.75.7
Alcohol175.65.6
Eltrombopag Olamine105.55.5
Liraglutide205.25.2
Nicotine165.05.0
Nicotine Polacrilex155.05.0
Abaloparatide114.84.8
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride104.14.1
Fam-Trastuzumab Deruxtecan-Nxki33.83.8
Ravulizumab43.83.8
Dulaglutide253.63.6
Tafamidis33.23.2
Diroximel Fumarate33.23.2
Tirzepatide282.22.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.